Francisco Javier Alvarez-Gutiérrez (Francisco Javier Álvarez-Gutiérrez)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Ejection Fraction

Top Venues

Patient preference and adherence

International journal of chronic obstructive pulmonary disease

Journal of asthma and allergy

Junta de Andalucia Servicio Andaluz de Salud

Universidad de Murcia (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Junta de Andalucia Servicio Andaluz de Salud Jan 01 1994

Spain

Unidad de Asma :: UMQER

Education History

Universidad de Murcia Jan 01 2015

Spain

MSC

Universidad de Granada

Spain

MSC :: medicina

Hospital Universitario Virgen del Rocío Dec 30 1995

Spain

PHD :: unidad medico quirurgica de enfermedades respiratorias

Universidad de Sevilla Jan 01 2006 - Jan 01 2015

Spain

MSC

Publications

Ana Gómez-Bastero Fernández, Juan Francisco Medina Gallardo, Julio Delgado Romero, Auxiliadora Romero Falcón, Cristina Benito Bernáldez, Javier Gallego Borrego, Francisco Javier Alvarez-Gutiérrez
Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma. Journal of asthma and allergy 15 (2022)
Francisco Javier Alvarez-Gutiérrez, Ana Gómez-Bastero Fernández, Juan Francisco Medina Gallardo, Carlos Campo Sien, Paula Rytilä, Julio Delgado Romero
Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study. Patient preference and adherence 15 (2021)
Luis A Perez-de-Llano, Marc Miravitlles, Rafael Golpe, Francisco Javier Alvarez-Gutiérrez, Carolina Cisneros, Carlos Almonacid, Eva Martinez-Moragon, Francisco-Javier Gonzalez-Barcala, David Ramos-Barbón, Vicente Plaza Moral, José Luis López-Campos, Juan Pablo de-Torres, Ciro Casanova, Juan Luis Garcia Rivero, Juan Luis Rodríguez Hermosa, Myriam Calle, Juan Jose Soler-Cataluña, Borja García Cosio
A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future. International journal of chronic obstructive pulmonary disease 15 (2020)